journal article·2016-03-02

Control of Protein Affinity of Bioactive Nanocellulose and Passivation Using Engineered Block and Random Copolymers

Maija Vuoriluoto, Hannes Orelma, Baolei Zhu, Leena-Sisko Johansson, Orlando J. Rojas

Publisher page

Abstract

We passivated TEMPO-oxidized cellulose nanofibrils (TOCNF) toward human immunoglobulin G (hIgG) by modification with block and random copolymers of poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA) and poly(oligo(ethylene glycol) methyl ether methacrylate) (POEGMA). The block copolymers reversibly adsorbed on TOCNF and were highly effective in preventing nonspecific interactions with hIgG, especially if short PDMAEMA blocks were used. In such cases, total protein rejection was achieved. This is in contrast to typical blocking agents, which performed poorly. When an anti-human IgG biointerface was installed onto the passivated TOCNF, remarkably high affinity antibody-antigen interactions were observed (0.90 ± 0.09 mg/m(2)). This is in contrast to the nonpassivated biointerface, which resulted in a significant false response. In addition, regeneration of the biointerface was possible by low pH aqueous wash. Protein A from Staphylococcus aureus was also utilized to successfully increase the sensitivity for human IgG recognition (1.28 ± 0.11 mg/m(2)). Overall, the developed system based on TOCNF modified with multifunctional polymers can be easily deployed as bioactive material with minimum fouling and excellent selectivity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Cellulose Research Studies · Nanofabrication and Lithography Techniques · Electrowetting and Microfluidic Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biobased Colloids and Materials (BiCMat), Department of Forest Products Technology, School of Chemical Technology, Aalto University, FI-00076, Espoo, Finland

DWI−Leibniz-Institute for Interactive Materials Research, Forckenbeckstr. 50, D-52056 Aachen, Germany

Funding

Suomen Akatemia · Seventh Framework Programme

References (57)

Show source-provided references
1. 10.1016/j.trac.2009.05.00510.1016/j.trac.2009.05.005 ↗
2. 10.1021/bm201676q10.1021/bm201676q ↗
3. 10.1021/bm300781k10.1021/bm300781k ↗
4. 10.1021/bm201771m10.1021/bm201771m ↗
5. 10.1007/s13758-012-0061-710.1007/s13758-012-0061-7 ↗
6. 10.1021/bm201236a10.1021/bm201236a ↗
7. 10.1039/C4RA08882D10.1039/C4RA08882D ↗
8. 10.1557/mrs.2013.6010.1557/mrs.2013.60 ↗
9. 10.1002/bit.1062510.1002/bit.10625 ↗
10. 10.1021/bm061197b10.1021/bm061197b ↗
11. 10.1038/3389410.1038/33894 ↗
12. 10.1021/bp010063110.1021/bp0100631 ↗
13. 10.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-810.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-8 ↗
14. Scott M. D. · Curr. Pharm. Des. · 1998 · 4 · 42310.2174/138161280406221011110509 ↗
15. 10.1021/la000736+10.1021/la000736+ ↗
16. 10.1021/la034111y10.1021/la034111y ↗
17. 10.1002/jbm.a.3132310.1002/jbm.a.31323 ↗
18. 10.1021/ja507372v10.1021/ja507372v ↗
19. 10.1021/jp411469u10.1021/jp411469u ↗
20. 10.1021/ac302874s10.1021/ac302874s ↗
21. 10.1021/am402118610.1021/am4021186 ↗
22. 10.1021/bm400797910.1021/bm4007979 ↗
23. 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M ↗
24. 10.1021/bm201661k10.1021/bm201661k ↗
25. 10.1021/la402494m10.1021/la402494m ↗
26. 10.1080/1073119050043022210.1080/10731190500430222 ↗
27. 10.1039/c3sm50578b10.1039/c3sm50578b ↗
28. 10.1021/ma980689g10.1021/ma980689g ↗
29. 10.1021/acs.jpcb.5b0762810.1021/acs.jpcb.5b07628 ↗
30. 10.1021/bm701317k10.1021/bm701317k ↗
31. Schasfoort R. B. M. · 2008
32. 10.1016/S0925-4005(98)00321-910.1016/S0925-4005(98)00321-9 ↗
33. 10.1021/la971228b10.1021/la971228b ↗
34. 10.1016/j.biomaterials.2007.01.04710.1016/j.biomaterials.2007.01.047 ↗
35. 10.1021/bm700904310.1021/bm7009043 ↗
36. 10.1116/1.218749510.1116/1.2187495 ↗
37. 10.1002/sia.182710.1002/sia.1827 ↗
38. 10.3183/NPPRJ-1989-04-02-p090-09310.3183/NPPRJ-1989-04-02-p090-093 ↗
39. 10.1007/s10570-010-9431-910.1007/s10570-010-9431-9 ↗
40. 10.1364/AO.27.00334110.1364/AO.27.003341 ↗
41. 10.1016/j.jcis.2013.08.00710.1016/j.jcis.2013.08.007 ↗
42. 10.1016/0022-1759(85)90150-410.1016/0022-1759(85)90150-4 ↗
43. 10.1002/elps.115006030510.1002/elps.1150060305 ↗
44. Malmsten, M.InChapter1. Protein adsorption at the solid-liquid interface;Lvov, Y.; Möhwadl, H., Eds.; Protein Architecture: Interfacing Molecular Assemblies and Immobilization Biotechnology;Marcel Dekker Inc.:New York, 2000; pp1–24.
45. 10.1021/jp993359m10.1021/jp993359m ↗
46. 10.1021/ma00193a07510.1021/ma00193a075 ↗
47. 10.1126/science.106717210.1126/science.1067172 ↗
48. 10.1177/29.11.617246610.1177/29.11.6172466 ↗
49. Boyle, M.InChapter 2.The type I bacterial Immunoglobulin-binding Protein: Staphylococcal Protein A; Bacterial Immunoglobulin Binding Proteins Vol. 1: Microbiology,Chemistry, and Biology; Academic Press, Inc:New York, 1990; pp17–28.10.1016/B978-0-12-123011-1.50006-X ↗
50. 10.1073/pnas.97.10.539910.1073/pnas.97.10.5399 ↗
51. 10.1038/nbt0787-69710.1038/nbt0787-697 ↗
52. 10.1021/bi00512a00110.1021/bi00512a001 ↗
53. 10.1016/j.bios.2014.02.06910.1016/j.bios.2014.02.069 ↗
54. 10.1021/la050329410.1021/la0503294 ↗
55. 10.1002/jbm.a.3410010.1002/jbm.a.34100 ↗
56. Vadgama Pankaj · 2013 · 2
57. 10.3390/s15010163510.3390/s150101635 ↗